1. Home
  2. GFR vs ALLO Comparison

GFR vs ALLO Comparison

Compare GFR & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFR
  • ALLO
  • Stock Information
  • Founded
  • GFR 2018
  • ALLO 2017
  • Country
  • GFR Canada
  • ALLO United States
  • Employees
  • GFR N/A
  • ALLO N/A
  • Industry
  • GFR
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GFR
  • ALLO Health Care
  • Exchange
  • GFR Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • GFR 349.6M
  • ALLO 338.9M
  • IPO Year
  • GFR N/A
  • ALLO 2018
  • Fundamental
  • Price
  • GFR $4.42
  • ALLO $1.18
  • Analyst Decision
  • GFR Buy
  • ALLO Strong Buy
  • Analyst Count
  • GFR 1
  • ALLO 10
  • Target Price
  • GFR $10.50
  • ALLO $9.66
  • AVG Volume (30 Days)
  • GFR 83.2K
  • ALLO 2.9M
  • Earning Date
  • GFR 05-06-2025
  • ALLO 05-13-2025
  • Dividend Yield
  • GFR N/A
  • ALLO N/A
  • EPS Growth
  • GFR N/A
  • ALLO N/A
  • EPS
  • GFR 1.79
  • ALLO N/A
  • Revenue
  • GFR $574,577,521.00
  • ALLO $22,000.00
  • Revenue This Year
  • GFR $3.00
  • ALLO N/A
  • Revenue Next Year
  • GFR $2.28
  • ALLO $9.07
  • P/E Ratio
  • GFR $2.20
  • ALLO N/A
  • Revenue Growth
  • GFR 32.30
  • ALLO N/A
  • 52 Week Low
  • GFR $3.82
  • ALLO $1.09
  • 52 Week High
  • GFR $8.16
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • GFR 40.93
  • ALLO 32.42
  • Support Level
  • GFR $3.81
  • ALLO $1.49
  • Resistance Level
  • GFR $4.85
  • ALLO $1.78
  • Average True Range (ATR)
  • GFR 0.29
  • ALLO 0.14
  • MACD
  • GFR -0.05
  • ALLO -0.03
  • Stochastic Oscillator
  • GFR 43.26
  • ALLO 13.04

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: